Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 32Terminated 14Active not recruiting 10Recruiting 7Unknown 6Withdrawn 3Suspended 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Pancreatic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Positron-Emission Tomography × Clear all
NCT05737615 2025-09-04

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Memorial Sloan Kettering Cancer Center

Phase 1 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT03300401 2019-05-16

Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization

University of Southern California

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT02059889 2016-12-16

Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer

Virginia Commonwealth University

Phase NA Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡